Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Orchid Pharma Ltd

NSE: ORCHPHARMA · BSE: 524372 · Pharmaceuticals & Biotechnology · 30 announcements

Share price
₹1,018.00
Market cap
₹6,096 Cr
Revenue (annual)
₹811.3 Cr
Net profit (annual)
₹20.55 Cr
P/E (TTM)
703.4×Sector 47.4×
Promoter holding
74.45%+4.61% QoQ
FII holding
0.92%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

19:34 IST NSE
Financial Results

Orchid Pharma Q4 FY26 Results: Net Profit ₹23.8 Cr, Up 6.7% YoY

Orchid Pharma Ltd reported revenue from operations of ₹237.6 Cr (+0.0% YoY) and net profit of ₹23.8 Cr (+6.7% YoY) for Q4 FY26.

Key figure
Net profit ₹23.8 Cr · +6.7% YoY
19:33 IST NSE
Financial Results

Orchid Pharma Financial Results

Orchid Pharma approved audited FY2026 results and appointed T R Chadha & Co. LLP as internal auditors. The consolidated net profit for the year stood at ₹21.21 Crore.